NVIDIA
NVDA
Tesla
TSLA
Super Micro Computer
SMCI
4
Palantir
PLTR
5
Hims & Hers Health
HIMS
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.32%595.41B | 1.05%162.26B | 3.85%160.11B | 2.91%140.24B | 1.46%132.8B | -13.26%581.91B | -9.49%160.58B | -18.27%154.17B | -15.06%136.28B | -9.35%130.89B |
Operating revenue | 0.97%587.59B | -3.32%160.24B | 3.72%158.15B | 2.82%138.31B | 1.33%130.89B | -13.26%581.91B | -10.03%165.75B | -18.09%152.48B | -15.06%134.52B | -9.12%129.17B |
Cost of revenue | 1.70%498.48B | 0.60%135.63B | 3.42%133.67B | 2.30%117.17B | 0.34%111.94B | -8.54%490.16B | -5.93%134.82B | -14.21%129.25B | -9.14%114.53B | -3.77%111.55B |
Gross profit | 5.64%96.93B | 3.38%26.63B | 6.08%26.43B | 6.09%23.07B | 7.91%20.87B | -32.00%91.76B | -24.45%25.76B | -34.38%24.92B | -36.78%21.74B | -32.07%19.34B |
Operating expense | 15.82%57.77B | 24.44%15.42B | 10.69%14.96B | 13.92%14.05B | 14.59%13.34B | -6.58%49.87B | -4.36%12.39B | -5.44%13.51B | -10.54%12.33B | -5.78%11.64B |
Selling and administrative expenses | 11.59%28.94B | 10.69%7.74B | 11.33%7.52B | 13.55%6.94B | 10.90%6.73B | -14.66%25.93B | -5.13%7B | -15.88%6.75B | -23.49%6.11B | -13.21%6.07B |
-Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | -5.07%6.57B | ---- | ---- | ---- | ---- |
-General and administrative expense | ---- | ---- | ---- | ---- | ---- | -17.49%19.36B | ---- | ---- | ---- | ---- |
Research and development costs | 13.06%28.83B | 10.44%7.68B | 10.06%7.44B | 14.28%7.11B | 18.61%6.61B | 4.63%25.5B | -0.01%6.95B | 7.94%6.76B | 7.30%6.22B | 3.92%5.57B |
Other operating expenses | ---- | ---- | ---- | ---- | ---- | -13.53%-1.55B | ---- | ---- | ---- | ---- |
Operating profit | -6.48%39.17B | -16.14%11.21B | 0.62%11.48B | -4.15%9.02B | -2.21%7.53B | -48.64%41.88B | -36.77%13.37B | -51.84%11.41B | -54.32%9.41B | -52.24%7.7B |
Net non-operating interest income expense | -2.21%-4.86B | 2.00%-1.31B | -3.53%-1.29B | -5.27%-1.16B | -2.88%-1.11B | -41.84%-4.76B | -19.70%-1.33B | -29.09%-1.25B | -56.70%-1.1B | -88.11%-1.08B |
Non-operating interest income | ---- | ---- | ---- | ---- | ---- | 131.14%1.51B | ---- | ---- | ---- | ---- |
Non-operating interest expense | -22.04%4.86B | -53.53%1.31B | 3.53%1.29B | 5.27%1.16B | 2.88%1.11B | 56.40%6.24B | 60.93%2.81B | 29.09%1.25B | 56.70%1.1B | 88.11%1.08B |
Total other finance cost | ---- | ---- | ---- | ---- | ---- | 60.67%33.18M | ---- | ---- | ---- | ---- |
Other net income (expense) | 34.49%7.38B | 346.96%1.54B | -0.91%2.08B | 25.29%2.25B | 15.27%1.44B | 53.57%5.49B | 6.97%344.1M | 133.18%2.09B | 46.02%1.8B | 11.50%1.25B |
Gain on sale of security | 37.86%4.29B | 21.69%1.23B | 29.73%947M | 71.35%1.24B | 35.65%879M | 61.67%3.11B | -23.58%1.01B | 1,116.67%730M | 200.00%726M | 114.57%648M |
Earnings from equity interest | -19.67%868M | -220.25%-133M | -26.07%485M | 40.80%459M | 575.00%57M | -8.84%1.08B | -22.32%110.6M | 83.24%656M | -32.92%326M | -106.03%-12M |
Special income (charges) | ---- | ---- | ---- | ---- | ---- | 407.89%600.71M | ---- | ---- | ---- | ---- |
-Less:Restructuring and merger&acquisition | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Less:Impairment of capital assets | ---- | ---- | ---- | ---- | ---- | -55.26%146.57M | ---- | ---- | ---- | ---- |
-Write off | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Gain on sale of business | ---- | ---- | ---- | ---- | ---- | 629.01%585.52M | ---- | ---- | ---- | ---- |
-Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---- | ---- | 42.70%161.76M | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 220.66%2.22B | 132.00%441M | -9.18%643M | -26.24%551M | -17.72%506M | 5.37%692.01M | -45.32%-1.38B | 47.50%708M | 48.21%747M | -0.97%615M |
Income before tax | -2.18%41.68B | -7.58%11.44B | 0.07%12.26B | 0.06%10.12B | -0.13%7.86B | -47.88%42.61B | -39.17%12.38B | -48.12%12.25B | -52.16%10.11B | -52.77%7.87B |
Income tax | 46.27%7.76B | 245.69%1.86B | -28.93%2.05B | 1.99%1.95B | 7.15%1.9B | -69.07%5.3B | -129.43%-1.28B | -42.73%2.89B | -57.27%1.91B | -45.79%1.78B |
Net income | -9.06%33.93B | -29.86%9.58B | 9.02%10.21B | -0.39%8.17B | -2.25%5.96B | -42.26%37.31B | -14.68%13.66B | -49.58%9.36B | -50.79%8.2B | -54.48%6.09B |
Net income continuous Operations | -9.06%33.93B | -29.86%9.58B | 9.02%10.21B | -0.39%8.17B | -2.25%5.96B | -42.26%37.31B | -14.68%13.66B | -49.58%9.36B | -50.79%8.2B | -54.48%6.09B |
Minority interest income | -22.00%1.44B | -49.81%267M | -7.85%540M | -16.41%382M | -0.72%274M | -40.64%1.85B | -38.54%531.95M | -46.92%586M | -31.69%457M | -42.26%276M |
Net income attributable to the parent company | -8.39%32.48B | -29.05%9.31B | 10.14%9.67B | 0.56%7.78B | -2.32%5.68B | -42.35%35.46B | -13.32%13.12B | -49.75%8.78B | -51.59%7.74B | -54.93%5.82B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -8.39%32.48B | -29.05%9.31B | 10.14%9.67B | 0.56%7.78B | -2.32%5.68B | -42.35%35.46B | -13.32%13.12B | -49.75%8.78B | -51.59%7.74B | -54.93%5.82B |
Basic earnings per share | -8.85%15.04 | -1.38%4.3 | 9.80%4.48 | 0.00%3.6 | -2.94%2.64 | -42.67%16.5 | -42.18%4.36 | -49.38%4.08 | -51.22%3.6 | -54.82%2.72 |
Diluted earnings per share | -10.07%14.46 | -2.82%4.14 | 8.50%4.34 | -0.57%3.5 | -1.54%2.56 | -41.78%16.08 | -40.34%4.26 | -48.98%4 | -12.87%3.52 | -55.48%2.6 |
Dividend per share | -42.21%10.2857 | 0 | 0 | -42.21%10.2857 | 0 | 28.38%17.7991 | 0 | 0 | 28.38%17.7991 | 0 |
Currency Unit | TWD | TWD | TWD | TWD | TWD | TWD | TWD | TWD | TWD | TWD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |